{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:18:46Z","timestamp":1785406726538,"version":"3.56.0"},"reference-count":106,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"crossref","award":["503\/1-002-01\/503-11-001"],"award-info":[{"award-number":["503\/1-002-01\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"crossref"}]},{"award":["503\/1-002-01\/503-11-001"],"award-info":[{"award-number":["503\/1-002-01\/503-11-001"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Polish Society for the Digestive Tract Diseases Neoplasms Prevention"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Ulcerative Colitis and Crohn\u2019s Disease are the most common forms of inflammatory bowel disease (IBD), with increasing prevalence both globally and in Poland. Many aspects of a patients\u2019 everyday functioning and treatment remain underexplored. Methods: This study recruited adult patients with IBD hospitalized in the Department of Digestive Tract Diseases of the Medical University of Lodz, Poland. The data were collected between June and July 2025 using an author-developed questionnaire assessing patients\u2019 opinions on therapy, their expectations, and overall life satisfaction. Results: A total of 87 patients with IBD were included in the analysis. Overall, 59 patients (67.82%) reported strong satisfaction with their current treatment, indicating a generally positive perception of disease management. Higher treatment satisfaction was associated with patients\u2019 perception that their preferences were respected by the gastroenterologist. Further analysis revealed significant associations between different types of treatment, disease activity, and patient-reported outcomes. Those patients who were treated with biological agents more frequently reported complete satisfaction with the treatment (41\/52 vs. 18\/35; p = 0.014), low-to-moderate disease activity (42\/52 vs. 19\/35; p = 0.016), and fewer limitations in their social lives (16\/52 vs. 20\/35; p = 0.026) compared to the remaining group. Furthermore, the study demonstrated that those patients who reported remission were less likely to have their physical activity limited (27\/55 vs. 27\/32; p = 0.002). There were significantly more patients under 50 years of age than older patients getting biological therapy (48\/74 vs. 4\/13; p = 0.045). Additionally, women in the studied group had a higher rate of IBD-related surgical interventions compared to men (15\/36 vs. 9\/51; p = 0.026). Despite the high overall satisfaction with treatment and physician communication, 20 patients (22.99%) admitted to taking additional, non-prescribed medication or dietary supplements. Similarly, 21 (24.14%) patients modified treatment regimens by discontinuing the medication intake or changing the prescribed dose. Furthermore, 57 patients (65.52%) reported that they feared the possibility of surgical intervention. Nonetheless, the majority of patients who underwent surgical treatment (22\/24; 91.67%) were satisfied with the results. Reported rates of undergoing regular colorectal cancer screening were also unsatisfactory\u20144\/37 (10.81%) patients with disease duration &gt; 8 years, suggesting inadequate awareness. Conclusions: Biological treatment can positively impact multiple aspects of patients\u2019 lives by lowering the disease\u2019s activity. Gastroenterologists should spend more time discussing patients\u2019 preferences and concerns, as well as explaining the colorectal cancer screening rules.<\/jats:p>","DOI":"10.3390\/jcm15093266","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:28:23Z","timestamp":1777040903000},"page":"3266","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preferences, Expectations and Management Satisfaction in IBD Patients: A Cross-Sectional Questionnaire-Based Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2012-5882","authenticated-orcid":false,"given":"Maja","family":"Mejza","sequence":"first","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bajer","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9336-3705","authenticated-orcid":false,"given":"Laura","family":"Biskup","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Duda","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4637-1264","authenticated-orcid":false,"given":"Julia","family":"Groszewska","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-1807","authenticated-orcid":false,"given":"Ewa","family":"Ma\u0142ecka-Wojciesko","sequence":"additional","affiliation":[{"name":"Department of Digestive Tract Diseases, Medical University of Lodz, 90-153 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Yang, K., Zhang, C., Gong, R., Jiang, W., Ding, Y., Yu, Y., Chen, J., Zhu, M., Zuo, J., and Huang, X. (2025). From West to East: Dissecting the Global Shift in Inflammatory Bowel Disease Burden and Projecting Future Scenarios. BMC Public Health, 25.","DOI":"10.1186\/s12889-025-24009-z"},{"key":"ref_2","first-page":"16194","article-title":"Nationwide Data on Epidemiology of Inflammatory Bowel Disease in Poland between 2009 and 2020","volume":"132","author":"Walkiewicz","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Perler, B., Ungaro, R., Baird, G., Mallette, M., Bright, R., Shah, S., Shapiro, J., and Sands, B.E. (2019). Presenting Symptoms in Inflammatory Bowel Disease: Descriptive Analysis of a Community-Based Inception Cohort. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-019-0963-7"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.mcna.2007.12.002","article-title":"Severe Complications of Inflammatory Bowel Disease","volume":"92","author":"Marrero","year":"2008","journal-title":"Med. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/ibd\/izae197","article-title":"A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease","volume":"31","author":"Gsenger","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/codi.15813","article-title":"Patients\u2019 Perceptions of Surgery for Inflammatory Bowel Disease","volume":"23","author":"Spinelli","year":"2021","journal-title":"Color. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of Surgery for Inflammatory Bowel Diseases Has Decreased over Time: A Systematic Review and Meta-Analysis of Population-Based Studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG Clinical Guideline: Management of Crohn\u2019s Disease in Adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2020.01.007","article-title":"AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis","volume":"158","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shehab, M., Alfadhli, A., Abdullah, I., Alostad, W., Marei, A., and Alrashed, F. (2024). Effectiveness of Biologic Therapies in Achieving Treatment Targets in Inflammatory Bowel Disease; Real-World Data from the Middle East (ENROLL Study). Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1388043"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s10238-023-00994-6","article-title":"Relapse Rates after Withdrawal versus Maintaining Biologic Therapy in IBD Patients with Prolonged Remission","volume":"23","author":"Stoker","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ibd\/izab248","article-title":"IBD Disability Index Is Associated with Both Direct and Indirect Costs of Inflammatory Bowel Disease","volume":"28","author":"Shafer","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jcag\/gwy038","article-title":"Addressing Mental Health in Persons with IBD","volume":"1","author":"Bernstein","year":"2018","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101672","DOI":"10.1016\/j.disamonth.2023.101672","article-title":"Factors Influencing the Quality of Life in Inflammatory Bowel Disease: A Comprehensive Review","volume":"70","author":"Khan","year":"2024","journal-title":"Dis. Mon."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5217\/ir.2017.15.3.338","article-title":"Impact of Inflammatory Bowel Disease on Daily Life: An Online Survey by the Korean Association for the Study of Intestinal Diseases","volume":"15","author":"Kim","year":"2017","journal-title":"Intest. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00365521.2024.2440794","article-title":"The Impact of IBD on Ability to Work and Study: A Patient Perspective","volume":"60","author":"Mustonen","year":"2025","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sochal, M., Ma\u0142ecka-Panas, E., Gabryelska, A., Talar-Wojnarowska, R., Szmyd, B., Krzywdzi\u0144ska, M., and Bia\u0142asiewicz, P. (2020). Determinants of Sleep Quality in Inflammatory Bowel Diseases. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092921"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijnurstu.2018.07.017","article-title":"Living with Inflammatory Bowel Disease: A Review of Qualitative Research Studies","volume":"87","author":"Fourie","year":"2018","journal-title":"Int. J. Nurs. Stud."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of Symptoms of Anxiety and Depression in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/bmb\/ldab010","article-title":"Psychological Factors Associated with Inflammatory Bowel Disease","volume":"138","author":"Eugenicos","year":"2021","journal-title":"Br. Med. Bull."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/s41598-021-81213-8","article-title":"Symptoms of Anxiety\/Depression Is Associated with More Aggressive Inflammatory Bowel Disease","volume":"11","author":"Gao","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11739-024-03764-8","article-title":"Association between Depression and Anxiety with the Risk and Flare of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","volume":"20","author":"Gong","year":"2025","journal-title":"Intern. Emerg. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/jgh.16568","article-title":"Systematic Review and Meta-analysis: Impact of Depression on Prognosis in Inflammatory Bowel Disease","volume":"39","author":"Ji","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/00365521.2022.2042593","article-title":"Inflammatory Bowel Disease: Perceived Impact on Leisure-Time Activities","volume":"57","author":"Mattila","year":"2022","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11739-019-02268-0","article-title":"Stigmatisation and Resilience in Inflammatory Bowel Disease","volume":"15","author":"Lenti","year":"2020","journal-title":"Intern. Emerg. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.14309\/ajg.0000000000000608","article-title":"Effect of Lifestyle Factors on Outcomes in Patients with Inflammatory Bowel Diseases","volume":"115","author":"Rozich","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ibd\/izae062","article-title":"Healthy Lifestyle Is a Protective Factor from Moderate and Severe Relapses and Steroid Use in Inflammatory Bowel Disease: A Prospective Cohort Study","volume":"31","author":"Gallego","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"otad067","DOI":"10.1093\/crocol\/otad067","article-title":"Knowledge and Attitude of Inflammatory Bowel Disease Patients Toward Colorectal Cancer Risk, Its Management, and the Role of Healthcare Providers: A Cross-Sectional Study in the UK","volume":"5","author":"Khan","year":"2023","journal-title":"Crohns Colitis 360"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00535-021-01811-1","article-title":"Physician\u2013Patient Communication Affects Patient Satisfaction in Treatment Decision-Making: A Structural Equation Modelling Analysis of a Web-Based Survey in Patients with Ulcerative Colitis","volume":"56","author":"Matsuoka","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.MIB.0000440983.86659.81","article-title":"The Burden of Inflammatory Bowel Disease","volume":"20","author":"Devlen","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2011.04.016","article-title":"Nutritional Problems in Inflammatory Bowel Disease: The Patient Perspective","volume":"5","author":"Prince","year":"2011","journal-title":"J. Crohns Colitis"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/ibd\/izac144","article-title":"Indirect Costs of Inflammatory Bowel Diseases: A Comparison of Patient-Reported Outcomes Across 12 European Countries","volume":"29","author":"Holko","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/S0002-9270(01)03896-5","article-title":"Quality of Health Care in Inflammatory Bowel Disease: Development of a Reliable Questionnaire (QUOTE-IBD) and First Results","volume":"96","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/00365521.2016.1195870","article-title":"Adherence and Quality of Care in IBD","volume":"51","author":"Bager","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_35","first-page":"96","article-title":"Satisfaction and Expectations of Patients with Inflammatory Bowel Disease on Biologic Therapy: A Multicenter Study","volume":"30","author":"Guarini","year":"2016","journal-title":"Ann. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ecco-jcc\/jjaa174","article-title":"WE-CARE IBD SCORE: Assessing High-Quality Care from the Perspective of Patients with Inflammatory Bowel Disease","volume":"15","author":"Barello","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/00365521.2015.1102319","article-title":"Patients\u2019 Perceptions of Quality of Care and Follow-up in Inflammatory Bowel Disease","volume":"51","author":"Bernklev","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/00365521.2018.1495759","article-title":"The Quality of Care Questionnaire: Development of a Valid Measure for Persons with Inflammatory Bowel Disease","volume":"53","author":"Katarina","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, Regional and National Burden of Inflammatory Bowel Disease in 204 Countries and Territories from 1990 to 2019: A Systematic Analysis Based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jgh.16099","article-title":"Trajectories of Health-Related Quality of Life and Fatigue during Vedolizumab Therapy in Inflammatory Bowel Disease","volume":"38","author":"Steenholdt","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CEG.S4512","article-title":"The Impact of Biologics on Health-Related Quality of Life in Patients with Inflammatory Bowel Disease","volume":"2","author":"Vogelaar","year":"2009","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.crohns.2012.01.019","article-title":"Restoration of Quality of Life of Patients with Inflammatory Bowel Disease after One Year with AntiTNF\u03b1 Treatment","volume":"6","author":"Casellas","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/13696998.2020.1791889","article-title":"The Cost-Effectiveness of Biologic versus Non-Biologic Treatments and the Health-Related Quality of Life among a Sample of Patients with Inflammatory Bowel Disease in a Tertiary Care Center in Saudi Arabia","volume":"23","author":"AlRuthia","year":"2020","journal-title":"J. Med. Econ."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Bellone, F., Morace, C., Impal\u00e0, G., Viola, A., Lo Gullo, A., Cinquegrani, M., Fries, W., Sardella, A., Scolaro, M., and Basile, G. (2023). Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?. J. Pers. Med., 13.","DOI":"10.3390\/jpm13060947"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Avedillo-Salas, A., Corral-Cativiela, S., Fanlo-Villacampa, A., and Vicente-Romero, J. (2023). The Efficacy and Safety of Biologic Drugs in the Treatment of Moderate\u2013Severe Crohn\u2019s Disease: A Systematic Review. Pharmaceuticals, 16.","DOI":"10.3390\/ph16111581"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/apt.14030","article-title":"Systematic Review with Meta-analysis: Comparative Efficacy of Biologics for Induction and Maintenance of Mucosal Healing in Crohn\u2019s Disease and Ulcerative Colitis Controlled Trials","volume":"45","author":"Cholapranee","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Mahlich, J., Matsuoka, K., and Sruamsiri, R. (2018). Biologic Treatment of Japanese Patients with Inflammatory Bowel Disease. BMC Gastroenterol., 18.","DOI":"10.1186\/s12876-018-0892-x"},{"key":"ref_48","first-page":"16287","article-title":"Biologic Treatment of Inflammatory Bowel Disease in Poland, 2012\u20132020: Nationwide Data","volume":"132","author":"Kucha","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_49","unstructured":"Ministry of Health of the Republic of Poland (2026, February 16). LECZENIE CHOROBY LE\u015aNIOWSKIEGO\u2014CROHNA (ChLC) (ICD-10 K 50), Available online: https:\/\/www.gov.pl\/web\/zdrowie\/obwieszczenie-ministra-zdrowia-z-dnia-17-wrzesnia-2025-r-w-sprawie-wykazu-refundowanych-lekow-srodkow-spozywczych-specjalnego-przeznaczenia-zywieniowego-oraz-wyrobow-medycznych-na-1-pazdziernika-2025-r."},{"key":"ref_50","unstructured":"Ministry of Health of the Republic of Poland (2026, February 16). LECZENIE PACJENT\u00d3W Z WRZODZIEJ\u0104CYM ZAPALENIEM JELITA GRUBEGO (WZJG) (ICD-10: K51), Available online: https:\/\/www.gov.pl\/web\/zdrowie\/obwieszczenie-ministra-zdrowia-z-dnia-17-wrzesnia-2025-r-w-sprawie-wykazu-refundowanych-lekow-srodkow-spozywczych-specjalnego-przeznaczenia-zywieniowego-oraz-wyrobow-medycznych-na-1-pazdziernika-2025-r."},{"key":"ref_51","unstructured":"Ministry of Health of the Republic of Poland (2026, February 16). OBWIESZCZENIE REFUNDACYJNE NR 74 (1 KWIETNIA 2024 r.), Available online: https:\/\/www.gov.pl\/web\/zdrowie\/obwieszczenie-ministra-zdrowia-z-dnia-17-wrzesnia-2025-r-w-sprawie-wykazu-refundowanych-lekow-srodkow-spozywczych-specjalnego-przeznaczenia-zywieniowego-oraz-wyrobow-medycznych-na-1-pazdziernika-2025-r."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/apt.15692","article-title":"Systematic Review with Meta-analysis: Biologics and Risk of Infection or Cancer in Elderly Patients with Inflammatory Bowel Disease","volume":"51","author":"Piovani","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.cgh.2018.12.032","article-title":"Safety of Biologic Therapy in Older Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis","volume":"17","author":"Borren","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_54","first-page":"494","article-title":"Pharmacoequity in Older Patients with Inflammatory Bowel Disease","volume":"20","author":"Kochar","year":"2024","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","article-title":"Natural History of Elderly-Onset Inflammatory Bowel Disease: A Population-Based Cohort Study","volume":"63","author":"Charpentier","year":"2014","journal-title":"Gut"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13555","DOI":"10.1038\/s41598-023-40624-5","article-title":"Treatment Strategy Changes for Inflammatory Bowel Diseases in Biologic Era: Results from a Multicenter Cohort in Japan, Far East 1000","volume":"13","author":"Taida","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/apt.16445","article-title":"Systematic Review: Societal Cost of Illness of Inflammatory Bowel Disease Is Increasing Due to Biologics and Varies between Continents","volume":"54","author":"Visser","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pakdin, M., Zarei, L., Bagheri Lankarani, K., and Ghahramani, S. (2023). The Cost of Illness Analysis of Inflammatory Bowel Disease. BMC Gastroenterol., 23.","DOI":"10.1186\/s12876-023-02648-z"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MEG.0000000000001031","article-title":"Quality of Life Related to Oral, Subcutaneous, and Intravenous Biologic Treatment of Inflammatory Bowel Disease: A Time Trade-off Study","volume":"30","author":"Holko","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/17474124.2021.1898944","article-title":"Patients with Inflammatory Bowel Disease (IBD) Prefer Oral Tablets over Other Modes of Medicine Administration","volume":"15","author":"Denesh","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Taxonera, C., Mart\u00ednez-Montiel, M.P., Barreiro-de-Acosta, M., Vera, I., Lorente, R., Vega, P., Diz-Lois, M.T., Fuentes Coronel, A.M., P\u00e9rez Calle, J.L., and Casis, B. (2021). Preferences and Satisfaction of IBD Patients after Switching from Adalimumab 40 Mg Weekly to 80 Mg Every Other Week given as a Single Injection: The ADASCAL Study. Ther. Adv. Gastroenterol., 14.","DOI":"10.1177\/17562848211056157"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2024.0798","article-title":"The Role of Novel Small Molecule Drugs in the Management of Inflammatory Bowel Disease","volume":"86","author":"Eden","year":"2025","journal-title":"Br. J. Hosp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e001916","DOI":"10.1136\/bmjgast-2025-001916","article-title":"Effectiveness and Safety of Upadacitinib in a Real-World Cohort of Patients with Crohn\u2019s Disease in the UK: A Multicentre Retrospective Cohort Study","volume":"12","author":"Danso","year":"2025","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"150676","DOI":"10.1016\/j.ijbiomac.2026.150676","article-title":"Oral Delivery of Infliximab via Self-Assembled Nano-in-Microspheres for Enhanced Inflammatory Bowel Disease Therapy","volume":"347","author":"Ding","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejpb.2020.08.017","article-title":"Exploiting Disease-Induced Changes for Targeted Oral Delivery of Biologics and Nanomedicines in Inflammatory Bowel Disease","volume":"155","author":"Zhang","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-Mediated Drug Delivery Systems for the Treatment of IBD: Current Perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"106379","DOI":"10.1016\/j.ejps.2023.106379","article-title":"Oral Infliximab Nanomedicines for Targeted Treatment of Inflammatory Bowel Diseases","volume":"183","author":"Mohan","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.7150\/thno.47601","article-title":"Oral Delivery of Anti-TNF Antibody Shielded by Natural Polyphenol-Mediated Supramolecular Assembly for Inflammatory Bowel Disease Therapy","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1007\/s10620-020-06567-x","article-title":"No Difference of Adalimumab Pharmacokinetics When Dosed at 40 Mg Every Week or 80 Mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification","volume":"66","author":"Paul","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/ibd\/izae015","article-title":"Patient Preferences for Treatment Attributes in Inflammatory Bowel Disease: Results from a Large Survey Across Seven European Countries Using a Discrete Choice Experiment","volume":"30","author":"Fiorino","year":"2024","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Godala, M., Gaszy\u0144ska, E., Durko, \u0141., and Ma\u0142ecka-Wojciesko, E. (2023). Dietary Behaviors and Beliefs in Patients with Inflammatory Bowel Disease. J. Clin. Med., 12.","DOI":"10.3390\/jcm12103455"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Picardo, S., Altuwaijri, M., Devlin, S.M., and Seow, C.H. (2020). Complementary and Alternative Medications in the Management of Inflammatory Bowel Disease. Ther. Adv. Gastroenterol., 13.","DOI":"10.1177\/1756284820927550"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ecco-jcc\/jjz051","article-title":"European Crohn\u2019s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease","volume":"13","author":"Torres","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.crohns.2011.09.007","article-title":"Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease: The Results of a Population-Based Inception Cohort Study (IBSEN)","volume":"6","author":"Opheim","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ibd\/izx043","article-title":"Patient Decision-Making About Emergency and Planned Stoma Surgery for IBD: A Qualitative Exploration of Patient and Clinician Perspectives","volume":"24","author":"Dibley","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/ecco-jcc\/jjab029","article-title":"The Burden of Inflammatory Bowel Disease in Europe in 2020","volume":"15","author":"Zhao","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"2022 European Society of Coloproctology (ESCP) CORREA Collaborating Group (2025). Towards Safer Colorectal Surgery Worldwide: Outcomes and Benchmarks from the ESCP CORREA 2022 Audit. Colorectal Dis., 27, e70281.","DOI":"10.1111\/codi.70281"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/00365520310004687","article-title":"What Concerns Subjects with Inflammatory Bowel Disease and an Ileostomy?","volume":"38","author":"Carlsson","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_79","first-page":"649","article-title":"Alcohol and Narcotics Use in Inflammatory Bowel Disease","volume":"31","author":"Mantzouranis","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.alcohol.2009.10.019","article-title":"Pattern of Alcohol Consumption and Its Effect on Gastrointestinal Symptoms in Inflammatory Bowel Disease","volume":"44","author":"Swanson","year":"2010","journal-title":"Alcohol"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","article-title":"Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-Analyses","volume":"157","author":"Piovani","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e000309","DOI":"10.1136\/bmjgast-2019-000309","article-title":"Current Smoking Habits in British IBD Patients in the Age of E-Cigarettes","volume":"6","author":"Chong","year":"2019","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ecco-jcc\/jjv113","article-title":"High Rates of Smoking Especially in Female Crohn\u2019s Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation\u2014Data from the Swiss IBD Cohort Study","volume":"9","author":"Biedermann","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/MIB.0b013e3182802b3e","article-title":"Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-Based Incident Cohort","volume":"19","author":"Lakatos","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Thomas, T., Chandan, J.S., Li, V.S.W., Lai, C.Y., Tang, W., Bhala, N., Kaplan, G.G., Ng, S.C., and Ghosh, S. (2019). Global Smoking Trends in Inflammatory Bowel Disease: A Systematic Review of Inception Cohorts. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221961"},{"key":"ref_86","first-page":"14","article-title":"Familial and Ethnic Risk in Inflammatory Bowel Disease","volume":"31","author":"Santos","year":"2017","journal-title":"Ann. Gastroenterol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00431-021-04269-8","article-title":"Increasing Rate of a Positive Family History of Inflammatory Bowel Disease (IBD) in Pediatric IBD Patients","volume":"181","author":"Ruban","year":"2022","journal-title":"Eur. J. Pediatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e001540","DOI":"10.1136\/bmjgast-2024-001540","article-title":"Patients and Clinicians Have Different Priorities When Discussing Pain in the IBD Clinic","volume":"11","author":"Huisman","year":"2024","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/ibd\/izaf054","article-title":"Health Outcomes, Discrimination, and Stigma Among Sexual and Gender Minority People with Inflammatory Bowel Disease","volume":"31","author":"Newman","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1053\/j.gastro.2021.12.200","article-title":"Stigma internalization in non-white patients with IBD and its relationship with patient outcomes","volume":"162","author":"Veracruz","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CEG.S83533","article-title":"A Systematic Review of Disease-Related Stigmatization in Patients Living with Inflammatory Bowel Disease","volume":"9","author":"Keefer","year":"2016","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/sjop.12914","article-title":"A Silent Burden: How Negative Experiences with Public Toilets Impact Quality of Life and Life Satisfaction","volume":"64","author":"Corradi","year":"2023","journal-title":"Scand. J. Psychol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"103512","DOI":"10.1016\/j.healthplace.2025.103512","article-title":"No Public Restroom: Illinois\u2019s Restroom Access Act and Bathroom Accessibility","volume":"95","author":"Weinmeyer","year":"2025","journal-title":"Health Place"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5223\/pghn.2020.23.3.286","article-title":"Quality of Life in Children and Adolescents with Inflammatory Bowel Disease: Impact and Predictive Factors","volume":"23","author":"Silva","year":"2020","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000443135","article-title":"The Future of IBD Therapy: Where Are We and Where Should We Go Next?","volume":"34","author":"Mao","year":"2016","journal-title":"Dig. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"23263","DOI":"10.1038\/s41598-025-06221-4","article-title":"Moderating Effects of Resilience and Depression on Social Support and Life Satisfaction in Patients with IBD: A Cross-Sectional Study","volume":"15","author":"Shen","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e75137","DOI":"10.2196\/75137","article-title":"Reddit as a Social Media Self-Management Tool for Inflammatory Bowel Disease: Qualitative Analysis","volume":"27","author":"Adeyemi","year":"2025","journal-title":"J. Med. Internet Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/SGA.0000000000000657","article-title":"Inflammatory Bowel Disease Self-Management: Exploring Adolescent Use of an Online Instagram Support Community","volume":"45","author":"Malloy","year":"2022","journal-title":"Gastroenterol. Nurs."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1089\/tmj.2020.0014","article-title":"Social Media Use for Inflammatory Bowel Disease in a Rural Appalachian Population","volume":"27","author":"Chowdhary","year":"2021","journal-title":"Telemed. e-Health"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e48020","DOI":"10.2196\/48020","article-title":"MHealth Physical Activity and Patient-Reported Outcomes in Patients with Inflammatory Bowel Diseases: Cluster Analysis","volume":"26","author":"Griffin","year":"2024","journal-title":"J. Med. Internet Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology Consensus Guidelines on the Management of Inflammatory Bowel Disease in Adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/pg.2023.125882","article-title":"Guidelines for the Management of Ulcerative Colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology","volume":"18","author":"Eder","year":"2023","journal-title":"Gastroenterol. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5114\/pg.2021.103666","article-title":"Guidelines for the Management of Patients with Crohn\u2019s Disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology","volume":"16","author":"Eder","year":"2021","journal-title":"Gastroenterol. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17474124.2021.1829971","article-title":"Patients\u2019 Perception of Colonoscopy and Acceptance of Colonoscopy Based IBD Related Colorectal Cancer Surveillance","volume":"15","author":"Braithwaite","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Burnett-Hartman, A.N., Hua, X., Rue, T.C., Golchin, N., Kessler, L., and Rowhani-Rahbar, A. (2019). Risk Interval Analysis of Emergency Room Visits Following Colonoscopy in Patients with Inflammatory Bowel Disease. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210262"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ibd.20049","article-title":"Does Colonoscopy Cause Increased Ulcerative Colitis Symptoms?","volume":"13","author":"Menees","year":"2007","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3266\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:14:58Z","timestamp":1778559298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/9\/3266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":106,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15093266"],"URL":"https:\/\/doi.org\/10.3390\/jcm15093266","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}